You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Pharmacy Articles
Popular Pharmacy Articles
Highly Recommended Pharmacy Articles
Send a link to this page to your friends and colleagues.
On February 28, 2006, sanofi-aventis announced that its fast-acting Apidra (insulin glulisine [rDNA origin] injection) is now available by prescription in the United States. Apidra was granted FDA approval in April 2004.
Sanofi-aventis says that Apidra should be used in regimens that include a longer-acting insulin or basal insulin analogue such as Lantus.
Sanofi-aventis also announced that Apidra cartridges are now available for use with the OptiClik insulin pen, which is also currently approved for use with Lantus.
In a sanofi-aventis press release, Richard M. Bergenstal, MD, executive director of the International Diabetes Center at Park Nicollet, Minneapolis, Minnesota, says, “Controlling mealtime blood sugar spikes is a crucial part of managing diabetes. Apidra is a welcome addition to the armamentarium of all healthcare professionals who treat adults with diabetes.”
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.